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Executive	  Summary	  	  
 
The purpose of this Work Project is to present a market overview of an industry and 
subsequent investment proposal for a Private Equity fund. The type of deal is a buy-
and-build of seven Portuguese optical retail chains and one hearing equipment retailer, 
with a holding period from 2014 to 2019. The cross selling of products is expected to 
lift up revenues, while cost synergies in procurement, personnel and general 
administrative expenses will increase operating margins. Provided the execution goes as 
planned, this investment is likely to generate strong returns for the fund’s shareholders, 
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1.	  Market	  Overview	  
1.1.	  Optical	  Retail	  
	  
Worldwide 
Optical retail stores are ubiquitous across the globe, fulfilling one extremely important 
need, eyesight improvement, through the sale of optical corrective equipment. Products 
fit into one of the following categories:  
• Lenses; 
• Frames; 
• Sunglasses - with or without prescription lenses; 
• Contact lenses; 
• Over-the-Counter spectacles - without a prescription of an ophthalmologist; 
• Others - cleaning products, p.e; 
The value chain is typically composed by two participants: manufacturers that produce 
the bulk eyewear equipment, and retailers, who resell it and tailor the products to 
prescriptions’ requirements. These products can either be from a licensed or a white 
label brand. There are several distribution channels to reach the consumer: optical 
independent stores, optical retail chains, mass merchandisers (Wal-Mart for example), 
department stores and others, such as online or street-selling. The relative importance of 
each channel is presented in Exhibit 1. 
 
In 2011, optical retail products had an estimated global market size of USD 81.0 Bn1, 
USD 63.0 Bn of which were attributed to eyeglasses. – Exhibit 2. The eyewear market 
is expected to grow by annually on average at 3.2% since 2013 to 20182, fueled by a 
larger consumer base and a higher penetration of the products. But not all products have 
the same outlook; for instance, sunglasses will grow at 8.1% per annum, on average3. 
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Some trends have been observed in the past years, which are sure to have an impact on 
the business model of optical stores and chains: 
• The world population is getting older: in 1993, approximately 6.3% of people had 
more than 65 years4; twenty years later that figure rose to 8.1%. One of the reasons 
is the increase in life expectancy at birth, from 65 to 71 years5. Since there is a larger 
penetration of optical equipment for older people (Exhibit 3), growing demand in 
the foreseeable future is expected; 
• Sedentary habits and the growing exposure to screens are increasing short 
sightedness. According to experts, 35% more young people suffer from it and the 
proportion could increase further 50% in the next 10 years6; 
• Glasses are used more and more as a fashion accessory; 
• Optical Retailers are entering the e-commerce market, already worth USD 9.4 Bn 
(27.1% of total sector revenue) in 2013 in the U.S7. 
 
With the ultimate purpose finding valuation multiples to later compute acquisition 
prices, a list of some of the largest optical retail chains was collected. For the complete 
list of the players, please refer to Exhibit 4. Overall the companies have had a moderate 
growth pattern and good profitability, evidenced by a 71% median Gross Margin and a 
median EBITDA margin of over 18%. They carried residual leverage and the multiples 
of EV/Revenue and EV/EBITDA were, respectively, 2.3x and 12.4x. 
Since November 2011, 58 known transactions (acquisitions of more than 20% stakes or 
management buy-outs) of optical retailers around the world were recorded - Exhibit 5. I 
used the Tukey Outlier filter to find any possible outlier the dataset might contain, with 
the following range:   𝑅𝑎𝑛𝑔𝑒 =    𝑄1 − 𝑘 ∗ 𝐼𝑄𝑅;𝑄3 + 𝑘 ∗ 𝐼𝑄𝑅 ,   
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𝑤ℎ𝑒𝑟𝑒  𝑘 = 1.5,𝑄1 = 1𝑠𝑡  𝑄𝑢𝑎𝑟𝑡𝑖𝑙𝑒,𝑄3 = 3𝑟𝑑  𝑄𝑢𝑎𝑟𝑡𝑖𝑙𝑒  𝑎𝑛𝑑  𝐼𝑄𝑅 = 𝐼𝑛𝑡𝑒𝑟𝑞𝑢𝑎𝑟𝑡𝑖𝑙𝑒  𝑅𝑎𝑛𝑔𝑒 
After finding the implicit, pre-deal valuation multiples of the analyzed transactions, I 
computed the average with the multiples of the publicly listed firms (with a 25% 






According to a study by the Portuguese Health Ministry, 52% of the population has a 
necessity of wearing glasses. Demand is created not only by health reasons, but also by 
aesthetical and comfort motives; for instance, more than 4 million people use 
sunglasses8. Thus, the sector is exposed to a broad consumer base and targets almost 
every age and socioeconomic group. Demand is likely to expand in the future, thanks to 
the economic upswing of the business cycle and an increasingly older population. Just 
as in the rest of the world, the proportion of old people is expected to grow, from 19% 
in 2011 to 25% in 20309. 
 
The Portuguese sector is composed almost exclusively by retailers that have to import 
the products from international players. The preferred way to reach costumers is 
through optical independent stores and chains. Still, and following their international 
counterparts, some hypermarkets have started selling optical equipment. Continente, 
through its Well’s brand, offers contact lenses and eye drops, while Jumbo Óptica sells 
all kinds of eye care products and also hearing devices and exams. 
  EV/Revenue EV/EBITDA 
M&A Multiples Median 1.41x 8.53x 
International Peers Median 1.71x 9.29x 
Average Medians 1.56x 8,91x 
Source: Zephyr; Gurufocus; Company’s reports 
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According to the National Optical Retailers Association, there were 1,218 companies 
operating last year, owning 1,700 stores across the country. With an average of 1.4 
stores per firm, the vast majority are family-owned SMEs, with turnover below Eur 1.0 
Mn. In fact, only 55, or 4.5%, had sales above this threshold (Amadeus database – 
Bureau Van Dijk). This makes it a poorly concentrated market, where the 10 biggest 
companies had 31.3% of total market share and whose Herfindahl-Hischmann index 
was 331 (out of 10,000). 
Scale is a very important condition in this industry and that is a reason why several 
companies have joined associations. The biggest, Instituto Óptico, has 182 stores and 
more than 80 associated retailers. Together, they have managed to achieve more 
bargaining power with suppliers which translates into higher gross margins, better 
access to credit facilities, the possibility to sell Instituto Óptico’s white label brand and 
leverage on its umbrella branding. 
 
The estimated market size in 2013 amounted to Eur 395.9 Mn, an increase of 5.4% from 
the previous year (Exhibit 6). Since 2010 it has grown at an average annual rate of 
1.0%, a small expansion, albeit higher than Portugal’s GDP negative evolution of -5.8% 
in the same period10. The sector’s profitability is not particularly high, with a median 
EBITDA margin of 8.5%. However, companies with turnover superior to Eur 1.0 Mn 
show higher margins (10.7%), which induce size as a determinant of performance. To 
further understand the profitability of the industry, I broke down the aggregated costs. 
The biggest cost drivers are Materials and Personnel expenses, which together amount 
to 67.3% of revenues. This is where the largest cost saving measures can be 
implemented, as I will argue later on.  




11% 5% 6% 
Revenues COGS Gross Margin Personnel SGA EBITDA Depreciations EBIT 
Aggregated Industry Cost Structure 






The selection of the targets to be purchased was based on several criteria: revenues 
within a threshold (above Eur 1.0 Mn and below Eur 5.0 Mn), ownership status (cannot 
be part of an international group) and number and location of stores (more than 5 shops, 
located in the North and Center of Portugal). The following firms were identified:  










Price (Eur Mn) 
Adão Oculista 2,4 -8,1% 6,3% -1,2 12 1,36 
Óptica Lince 2,3 -0,7% 12,6% 1,9 13 2,57 
Carlos & Leonor - Óptica 2,0 2,1% 4,2% 7,2 12 0,74 
Antunes Oculistas 1,7 -12,5% 2,3% -0,9 9 0,35 
Jaime Oculista 1,4 -1,7% 14,0% -0,1 7 1,74 
Ópticas Parente II 1,2 -0,4% 15,7% 0,6 6 1,53 
Alípios 1,0 n.a. 15,9% -0,2 5 1,44 
 
1.2 Hearing Equipment Retail 
Worldwide 
A hearing aid equipment is a small electronic device that allows the user to restore part 
of the lost hearing ability. It has three components: a microphone, an amplifier and a 
speaker. The microphone receives sound, transforms it into electrical signals and sends 
them to the amplifier. Then, the power of the signals is increased in the amplifier and 
sent to the speaker, which will transmit it to the ear. There are several types of products 
available: behind the ear, receiver in the ear, in the ear, completely in the canal, body-
worn aids and cochlear implants. 
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Typically, two types of players are involved: manufacturers of the equipment and 
retailers, who distribute it and sell it to the final costumer. The channel mix is 
comprised of four alternative ways to reach the client: large retail chains, manufacture 
retail, independent dispensers and public, such as the U.S. Veteran Affairs - Exhibit 8. 
 
The global retail hearing aid equipment is estimated to be worth around USD 5.4 Bn in 
2012, with long-term growth rates of 3-6% driven by demographic development, 
according to a study by Sanford C. Bernstein (Beremberg pinpoints a CAGR of 4.5% 
for the next 6 years). In 2013, 10.8 million units were sold, an increase from 9.4 million 
two years prior and 8.5 million in 2009 (CAGR of 6.3%)11. Demand is higher in 
developed economies, with Europe and the U.S. responsible for 41% and 29% of sold 
units, respectively. According to the World Health Organization, market penetration is 
extremely low; Portugal, with 4.5%, is in the bottom range. 
Key trends that accelerated in the past decade are expected to feed growth and finally 
increase a stubbornly low penetration11: 
• Technological advances such as wireless connectivity with other devices, lower 
background noise or tailoring hearing characteristics to different occasions; 
• Substantial size reduction; 
• Aging of the population and longer life expectancy across the world; 
• Bigger exposure to noise pollution and hearing-related diseases. 
Six companies dominate the global market: Sonova, William Demant, Siemens’ 
Hearing Division (on the verge to be acquired), GN Store Nord, Starkey and Widex, 
with a combined market share of 98%. Rion, a Japanese manufacturer, was also 
included to provide a more representative sample – Exhibit 9. 
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Since November 2011, 32 known transactions whose target was a hearing aid 
manufacturer were registered (Exhibit 10). After excluding outliers of the dataset using 
the Tukey range, I managed to compute the valuation multiples of the transactions. 
Using the previous information from international comparables (with the illiquidity 






One of the factors with the biggest influence in the demand for this kind of product is 
demographics. In Portugal approximately 10% of the population has some sort of 
hearing loss; that figure rises to 60% for people with more than 65 years12. 90% of those 
cases can be corrected with the use of a simple hearing device (i Journal). Even though 
the future looks rosy, manufacturers and retailers have failed to increase market 
penetration, even comparing with international low standards. 
In Portugal, there are 23 companies that operate in the hearing equipment retail sector, 
with a combined turnover of Eur 58.2 Mn. Having registered strong growth of 16% 
from 2005 to 2009 (CAGR; Amadeus), the market is down 3.8% since 2010. Five 
companies dominate the market, with an aggregate market share of 91.9% (Exhibit 11) 
and only seven firms report sales higher than Eur 1.0 Mn, making it extremely 
concentrated. 
The five biggest, Hidden Hearing, Minisom, GAES, Widex and Amplifon, all belong to 
multinational groups and benefit from lower procurement costs. Due to this ownership 
  EV/Revenue EV/EBITDA 
M&A Multiples Median 1.00x 8.46x 
International Peers Median 1.85x 9.40x 
Average Medians 1.43x 8.93x 
Source: Zephyr; Gurufocus; Company’s reports 
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restriction and minimum needed size, the selected company to be acquired is Casa 
Sonotone (together with the subsidiary Audiosom), the sixth largest player: 









Casa Sonotone + Audiosom 2,1 -10,3% 8,4% -0,4 Eur 1,57 Mn 
 
	  
2	  –	  Investment	  Strategy	  
2.1 Deal Structuring 
The type of deal is a buy-and-build, where a platform company is created and multiple 
acquisitions are added to, throughout 2015. The purchase of the targets will be financed 
through a mixture of equity from the Private Equity fund and the management team 
(Eur 8.95 Mn and Eur 0.23 Mn, respectively), and senior debt (Eur 2.70 Mn), parked on 
the new holding. The amount of contracted debt was chosen as to reach a Net 
Debt/Ebitda of 2.5x in 2014. Payments occur annually in equal installments until 2019.  
The investment case presented assumes the full acquisition of the targets’ equity, 
although an asset deal or a carve-out of non-core assets are options to be considered. 
The acquisition price of the targets has as a reference the EV/Ebitda multiple of each 
sector, previously computed. 
 
2.2 Value Creation Drivers 
On this particular deal, there are predominantly three value creation drivers, all related 
to the fundamentals of the business: 
• Revenue push-up by cross-selling hearing equipment in optical retail stores. 
Supporting this argument are a relevant capillarity of optical stores (opposed to the 
almost inexistence of hearing equipment selling places), a similar customer profile, 
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13% 23% 
36% 35% 29% 
87% 77% 
64% 65% 71% 
2015	   2016	   2017	   2018	   2019	  
Value Creation Drivers 
(% of EBITDA Growth, 2015-19) 
Revenue Growth Cost Synergies 
the creation of a single brand with national reach and a broader product offering. The 
number of stores to have both products is to increase gradually, from 9 to 33 
(Exhibits 12 and 13); 
• Reduction of material costs of eyecare products by merging procurement functions 
and purchasing equipment for the group as a whole; 
• Leaner cost structure in the items of Personnel (human resources, marketing and 
management team) and SG&A, such as cleaning, insurance, fuel, communications, 
outsourced accountancy and ERP software licenses. 
Below is a chart that demonstrates the source of the increase of fundamentals: more 








The investment has a time horizon of five years, starting with the first acquisitions in 
December 2014 and with the sale of the group occurring in the end of 2019/early 2020. 
After initiating talks with the targets in October 2014 and the Legal and Financial Due 
Diligences are completed by November, the Private Equity fund should start 2015 by 
acquiring Casa Sonotone and the two biggest optical retail chains (Adão Oculista and 
Ópticas Lince), as well as recruiting the management team. During 2015, the remaining 
optical chains will be acquired, the majority of the cost reduction measures will take 
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place and hearing equipment will begin to be sold in nine stores. After that, the number 
of stores that sell hearing equipment will gradually increase, peaking at thirty-three by 
2019 (Exhibit 14). 
 
2.4 Management and Alignment of Interests  
For this investment, the management team will be centralized and composed by a CEO, 
who will take charge of acquisitions, business development and reporting, a CFO with 
responsibilities over human resources, accounting/treasury and legal, and a COO, who 
will oversee procurement, quality and marketing. The Board of Directors will have as 
members the previously mentioned executives and a partner of the private equity fund 
as a non-executive chairman. The compensatory packages are composed by a base 
salary, lunch allowance and fringe benefits, which comprises of car, fuel, cell phone and 
medical insurance for 4 members of the family – Exhibits 15 and 16. 
In Private Equity, one of the most crucial aspects is the correct alignment of interests of 
the management team and the fund’s objectives (and, ultimately, shareholders). Two 
mechanisms will ensure the management has a motivation to drive up results: 
management equity and performance bonus.  
The first one forces the acquisition of small stakes by the management team (CEO by 
1.0% and CFO/COO 0.75% each) in cash and at the beginning of the investment. By 
having “skin in the game”, it will in their best interest to maximize the valuation of the 
company. The second mechanism ties bonuses to the EBITDA generated in 2019: if it 
surpasses Eur 2.5 Mn or Eur 3.0 Mn, a bonus of 40% or 80% of annual salary will be 
awarded to them, respectively, in the following year. 
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3	  –	  Business	  Plan	  
3.1	  Base	  Scenario	  
	  
The investment plan relies on a large number of assumptions, as follows: 
• The acquisition of the companies will contemplate the creation of goodwill (Eur 
4.05 Mn) and assume no other adjustments of assets and liabilities (such as PP&E). 
The costs of the legal and financial due diligences and legal & miscellaneous fees 
are estimated to be Eur 60,000 for each target, already accounted in the purchase 
price and to be paid in cash by the holding, in late 2014. 
• Previously existing debt (short and long-term) in the companies will be totally paid 
off in equal installments over the investment period. 
• No dividend payout through the investment cycle; free cash flows will be applied in 
reducing debt over the period; 
• Flat revenues for optical products and sales increase for hearing equipment. The 
average retail price was estimated with a U.S benchmark ($3,600 for a binaural 
equipment) and corrected for Portugal’s Purchase Price Parity and the EUR/USD 
exchange rate, at 21/11/2014. Average quantities sold on each store will increase 
from ten to eighteen units each year. The number of stores that sell both products 
will start as 9 in 2015 and increase to 33 in 2019 (52% of the total number of 
shops). The rationale for cherry-picking the stores is potential cannibalization across 
the same district on the face of conservative demand forecasts. 
• Material costs reduction of optical products by 10%, starting in 2015. As for hearing 
devices, the reduction will be steadily achieved, calculated by multiplying the 
increasing revenues in percentage points by a scale factor of 0.1. 
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• SG&A savings in fuel, communication, insurance and cleaning expenses amount to 
5% of the historical values. ERP annual licenses’ renewal was computed to be 15% 
of the price of the software (€4,000), which will be scrapped by using only one 
product. Outsourced accountancy will be used for the group, at a cost of €2,000, 
instead of  €1,000 for each of the eight companies. 
• Centralization of personnel dedicated to HR and Marketing; two people of each 
function in the group, opposed to one per company currently. However, one 
audiologist will have to be allocated to each store that sells hearing equipment.  
• Other Costs and Benefits and Non-Current Liabilities remain unchanged. Steady 
Depreciations and Amortizations, equal to annual Capital Expenditures. No 
additional optical stores will open. 
• Transportation costs of hearing equipment, 3 annual trips to each cross-selling store, 
at an average cost of €70 per store. 
• Initial investment in 2015 to upgrade stores image, develop a new brand and logo 
and marketing expenses. The latter includes advertisement in billboards (€1,000 for 
every store) and search engine optimization (at €3,000 per year). Furniture to 
display hearing equipment is to be bought, for every shop that starts selling it, at 
€200 each. 
• Tax rate would move to superior stage of 31.5% but reduced to 29.5% in 2015 and 
27.5% in 2016 onwards thanks to a corporate tax reform; 
• Days Payables Outstanding will stay at 209 and Days Sales Outstanding at 94. Days 
Inventory Outstanding for optical products will decrease from 374 days to 320 as a 
result of a centralized procurement function that will optimize stock management. 
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According to the business plan, by 2019, sales will have grown to EUR 16.1 Mn, a 
CAGR of 2.7% since 2014. Gross Margin will increase from 64.8% to 68.8% and 
EBITDA Margin will reach 17.9%, up 8.8 percentage points since the beginning of the 
investment. Net Debt/EBITDA will systematically decrease, from 2.5 in 2014 to -0,9 in 
2019, reflecting the deleveraging process.  
Working Capital 2013 2014 2015 2016 2017 2018 2019 
Days Sales Outstanding 94 94 94 94 94 94 94 
   Eyecare Retail 102 102 102 102 102 102 102 
   Hearing Equipment 49 49 49 49 49 49 49 
Days Inventory Outstanding 349 349 300 300 300 300 300 
   Eyecare Retail 374 320 320 320 320 320 320 
   Hearing Equipment 147 147 147 147 147 147 147 
Days Payable Outstanding 209 209 209 209 209 209 209 
   Eyecare Retail 252 252 252 252 252 252 252 
   Hearing Equipment 107 107 107 107 107 107 107 
Cash Conversion Cycle 234 234 185 185 185 185 185 
   Eyecare Retail 224 170 170 170 170 170 170 
   Hearing Equipment 89 89 89 89 89 89 89 
         
Net Debt/EBITDA 0,7 2,5 0,9 0,4 0,0 -0,4 -0,9 
 
Group Income Statement and 5-Year Projections 
Eur '000 2013 2014 2015 2016 2017 2018 2019 
Revenues 14 076 14 076 14 173 14 379 14 815 15 415 16 054 
COGS 4 960 4 960 4 542 4 593 4 698 4 846 5 007 
Gross Margin 9 116 9 116 9 631 9 787 10 117 10 570 11 047 
% of Revenues 64,8% 64,8% 68,0% 68,1% 68,3% 68,6% 68,8% 
Personnel 4 925 4 925 4 715 4 858 5 084 5 166 5 207 
% of Revenues 35,0% 35,0% 33,3% 33,8% 34,3% 33,5% 32,4% 
SG&A 3 201 3 201 3 281 3 248 3 251 3 250 3 250 
% of Revenues 22,7% 22,7% 23,1% 22,6% 21,9% 21,1% 20,2% 
Other Gains/Expenses -290 -290 -290 -290 -290 -290 -290 
% of Revenues -2,1% -2,1% -2,0% -2,0% -2,0% -1,9% -1,8% 
         EBITDA 1 280 1 280 1 926 1 971 2 072 2 444 2 881 
% of Revenues 9,1% 9,1% 13,6% 13,7% 14,0% 15,9% 17,9% 
Dep & Amortizations 613 613 613 613 613 613 613 
         
EBIT 667 667 1 313 1 359 1 460 1 831 2 268 
% of Revenues 4,7% 4,7% 9,3% 9,4% 9,9% 11,9% 14,1% 
Financial Expenses 109 109 254 192 139 88 44 
         EBT 559 559 1 060 1 167 1 321 1 744 2 224 
Taxes 171 170 313 321 363 480 612 
Net income 388 388 747 846 958 1 264 1 612 
% of Revenues 2,8% 2,8% 5,3% 5,9% 6,5% 8,2% 10,0% 
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Group Cash Flow Statement and 5-Year Projections 
Eur '000 2014 2015 2016 2017 2018 2019 
Cash Flows from Operating Activities             
Inflows             
   Sales 14 076 14 151 14 326 14 703 15 261 15 890 
Outflows             
    Materials 4 960 3 751 4 584 4 680 4 821 4 980 
    SG&A 3 201 3 281 3 248 3 251 3 250 3 250 
    Personnel 4 925 4 715 4 858 5 084 5 166 5 207 
    Taxes 170 313 321 363 480 612 
    Other Gains/Expenses -290 -290 -290 -290 -290 -290 
Net Cash Flow Operations 1110 2382 1606 1615 1835 2132 
Cash Flows from Investing Activities             
    Capital Expenditures 613 613 613 613 613 613 
Net Cash Flow Investing -613 -613 -613 -613 -613 -613 
Cash Flows from Financing Activities             
    Financial Expenses 109 254 192 139 88 44 
    Debt Payment 0 1833 964 964 964 964 
Net Cash Flow Financing -109 -2086 -1155 -1102 -1051 -1008 
              
Net Variation of Cash 388 -316 -162 -100 171 511 
              
Cash Beginning of the Year 2 099 2 488 2 171 2 009 1 909 2 080 
Cash End of Year 2 488 2 171 2 009 1 909 2 080 2 591 
Group Balance Sheet and 5-Year Projections 
	  
Eur '000 2013 2014 2015 2016 2017 2018 2019 
Fixed Assets 4 568 8 623 8 623 8 623 8 623 8 623 8 623 
Intangible Fixed Assets 230 230 230 230 230 230 230 
Tangible Fixed Assets 4 058 4 058 4 058 4 058 4 058 4 058 4 058 
Other Fixed Assets 279 279 279 279 279 279 279 
Goodwill 0 4 055 4 055 4 055 4 055 4 055 4 055 
                
Current Assets 10 465 10 854 9 533 9 444 9 499 9 884 10 625 
Inventory 4 738 4 738 3 712 3 732 3 775 3 834 3 899 
Accounts Receivable 3 629 3 629 3 650 3 703 3 815 3 970 4 135 
Cash & Cash Equivalents 2 099 2 488 2 171 2 009 1 909 2 080 2 591 
Total Assets 15 033 19 476 18 156 18 067 18 121 18 507 19 248 
Capital 454 8 793 8 793 8 793 8 793 8 793 8 793 
Other shareholder's funds 6 987 388 1 136 1 981 2 939 4 203 5 816 
Equity 7 441 9 181 9 928 10 774 11 732 12 996 14 608 
Non-Current Liabilities 2 337 5 041 4 077 3 114 2 150 1 187 223 
Long-term Debt 2 114 4 818 3 854 2 891 1 927 964 0 
Other non-Current Liabilities 223 223 223 223 223 223 223 
                
Current Liabilities 5 254 5 254 4 150 4 179 4 239 4 324 4 416 
Loans 869 869 0 0 0 0 0 
Accounts Payable 2 836 2 836 2 601 2 630 2 690 2 775 2 867 
Other Current Liabilities 1 549 1 549 1 549 1 549 1 549 1 549 1 549 
Total Liabilities 7 592 10 295 8 227 7 293 6 390 5 511 4 639 
                
Total Liabilities + Equity 15 033 19 476 18 156 18 067 18 121 18 507 19 248 
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3.2	  Adverse	  Scenarios	  
	  
To test for the resilience of the operating profitability of the investment, two different 
negative scenarios were considered. Under the first one, the acquisition of the hearing 
retailer Casa Sonotone could not be performed. This would nullify the revenue increase 
and make cost reduction the only value creation driver. Assuming the same Net 
Debt/Ebitda target as in the base case of 2.5x, under this scenario EBITDA would reach 
EUR 1.9 Mn, or 15.5% of sales, in 2019 (Exhibit 17). 
On the other situation, the reduction of material costs of both products would fail to 
materialize. As a consequence, the overall group’s gross margin would increase to only 
65.9% of turnover (still a positive effect due to higher margins of hearing devices). 
Nonetheless, the EBITDA margin would still jump to 15.0% (Exhibit 17). 
 
4	  –	  Exit	  and	  Returns	  
4.1	  Exit	  Opportunities	  
	  
Private Equity investments have three exit options: an IPO, a trade sale or a secondary 
buy-out, to another private equity fund. Given a dynamic M&A activity (45 known 
transactions of optical retailers since November 2011) and the existence of valuable 
attributes that this investment can generate, the preferred option would be a trade sale.  
There are two types of companies that would clearly benefit from a deal: optical retail 
chains that are present in the Portuguese market and want to grow their market share or 
large, foreign optical retailers that want to expand to other countries through non-
organic growth. In the case of the former, only GrandVision (owned by H.A.L. Trust) 
has the scale and means to acquire our group; however, it would most likely be blocked 
by the regulatory entity on the grounds of a dominant position. The latter group 
	   16	  
comprises global firms such as Luxottica or Fielmann, who have large amounts of cash 
(USD 1.7 Bn and USD 243.0 Mn, respectively), or smaller European optical retailers. 
Still, it would be somewhat reckless to overlook the possibility of a secondary buy-out. 
In the analyzed transactions sample, 16 (or 36%) were deals of this type. Despite the 
most immediate benefits would already been taken, further growth would be possible, 
not least by making all the stores selling hearing equipment. Alain Afflelou, for one, 
was acquired by Lion Capital as a tertiary buy-out. Potential buyers would be small-
market European Private Equity funds and their Portuguese brethren. 
4.2	  Financial	  Returns	  
	  
Assuming no multiple arbitrage on the sale (implicit EV/Ebitda of 8.91x), the proposed 
investment would generate a cash multiple of 2.80x and an IRR of 22,8%. After testing 
for the two different scenarios and another with an exit multiple of 7.0x, the returns 
proved to be fairly resilient, dropping no lower than 1.89x and 13,6%, respectively.  
  Base Case 
Without Casa 
Sonotone 
No Material Cost 
Reduction Exit Multiple 7.0x 
Sales 16 054 11 997 16 054 16 054 
EBITDA 2 881 1 859 2 408 2 881 
EBITDA Margin 17,9% 15,5% 15,0% 17,9% 
          
Equity Entry 8 951 8 232 8 951 8 951 
Equity Exit 25 025 15 589 20 906 19 660 
MOIC 2,80x 1,89x 2,34x 2,20x 
IRR 22,8% 13,6% 18,5% 17,0% 
 
Two of the most critical variables affecting the returns of the investment were the 
expected savings in materials costs of eyecare products and the reduction of operational 
costs, namely Personnel and SG&A. To assess the sensitivity of the investment’s 
profitability on these items, the following data tables were created. Exhibit 18 addresses 
the relationship between profitability and the amount of debt contracted. 
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    % Reduction Material Costs of Eyecare Products 
  Multiple on Invested Capital 0% 5% 10% 15% 20% 
        0% 1,62x 1,83x 2,05x 2,26x 2,48x 
Reduction in 
pp. of SG&A 
and Personnel 
2% 1,93x 2,15x 2,36x 2,57x 2,79x 
4% 2,24x 2,46x 2,67x 2,89x 3,10x 
6% 2,55x 2,77x 2,98x 3,20x 3,41x 
  8% 2,87x 3,08x 3,29x 3,51x 3,72x 
 
 
  % Reduction Material Costs of Eyecare Products 
 IRR 0% 5% 10% 15% 20% 
  0% 10,1% 12,9% 15,4% 17,7% 19,9% 
Reduction in 
pp. of SG&A 
and Personnel 
2% 14,1% 16,5% 18,7% 20,8% 22,8% 
4% 17,5% 19,7% 21,7% 23,6% 25,4% 
6% 20,6% 22,6% 24,4% 26,2% 27,8% 
  8% 23,4% 25,2% 26,9% 28,5% 30,1% 
 
I then performed a valuation of the holding company using the Discount Free Cash 
Flow to Firm (FCFF), as a safety check for the returns obtained from the multiples 
approach.  The Weighted Average Cost of Capital (Exhibit 21) was calculated for the 
appropriate discount rate, with the following premises: 
• The discount rate of Equity was computed using the Capital Asset Pricing Mode, 
where the risk-free rate was the Yield-to-Maturity of Portuguese 10-Year 
Government Bonds13 (2.75% at 29/12/2014), the Market Risk Premium was 7.39% 
(Damodaran’s Equity Country Risk)14 and the Market Beta15 of Healthcare Products 
of 0.89 – Exhibit 19; 
• The discount rate of Debt for every year was calculated adding the effective annual 
rates of Euribor 3 Months estimates and a spread of 4.0% – Exhibit 20; 
• The Terminal Value was achieved using the Ebitda multiple (same multiple of entry) 
instead of a perpetuity, since the holding period of the investment is only 5 years. 
Discounted to the present day, the Equity in 2019 would be Eur 22.6 Mn, not far from 
the values obtained from the multiples, Eur 25.0 Mn. To see the table that summarizes 
the valuation, please refer to Exhibit 21. 
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5	  –	  Recommendation	  
	  
I believe this proposal provides an interesting investment opportunity to be pursued, 
considering the following: 
ü Highly fragmented market, with more than 1,200 retailers and 1,700 stores. Only 
4.5% of the companies had turnover superior to Eur 1.0 Mn; 
ü Relevant market size (Eur 395.6 Mn) and fair profitability (median EBITDA margin 
of 10.5%). Demographic and cultural trends support demand in the long term for 
both eyecare and hearing aid equipment; 
ü International optical retail chains such as Specsavers or Fielmann have started 
selling hearing equipment. Similar customer profiles, the expansion of product 
offering and access to optical stores’ capillarity will increase the penetration of 
hearing equipment, which has higher margins; 
ü Potential to obtain cost synergies with the creation of a larger player, in 
procurement, personnel and administrative expenses; 
ü Expected annual rate of return exceeds 22% and the multiple on invested capital is 
2.80x. After testing with adverse scenarios, they still remain attractive. Creation of 
value will be achieved through operational improvements, both on the revenue and 
cost side and opposed to financial leverage. 
However, there are some risks associated. To begin with, the execution relies on the 
acquisition of eight specific targets; regarding hearing retailers, Casa Sonotone is 
essentially the only available target. Secondly, customers may not associate the sale of 
hearing devices in optical stores, thus nullifying the expected revenue increase. Finally, 
expected cost savings might fail to materialize, which would have an impact on the 
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investment profitability. Despite this, I believe the investment’s returns outweigh its 
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Exhibit 1 – Distribution Channels of Eyewear in the U.S 
 



























Eyewear Lenses (2012) Frames (2013) Sunglasses (2011) Contact Lenses (2012) OTC (2013) 
Distribution Channels of Eyeware in the U.S. 
(% of total, latest available data) 
Optical Independent Stores Optical Retail Chain Mass Merchandisers 
Department Stores Other Sunglass Specialty Stores 
Source: Statista 
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Exhibit 3 – Adults wearing corrective eyewear in the UK 








Source: The College for Optometrists UK, 2013 
 
Exhibit 4 – List of International Optical Retail Peers 















H.A.L. Trust 4 115 3,0% 16,5% 67,9% 5 046 2,1 11,3 0,0 
Specsavers 1 800 8,9% 6,0% 47,4% 1 662 n.a. n.a. n.a. 
Vision Source 1 551 n.a. n.a. n.a. 2 797 n.a. n.a. n.a. 
Walmart Vision 1 163 n.a. n.a. n.a. 3 202 n.a. n.a. n.a. 
Fielmann 1 160 5,2% 17,3% 78,2% 679 2,5 13,6 -0,7 
Visionworks 618 n.a. n.a. n.a. 619 n.a. n.a. n.a. 
National Vision 614 n.a. n.a. n.a. 745 n.a. n.a. n.a. 
Costco Optical 596 n.a. n.a. n.a. 440 n.a. n.a. n.a. 
Apollo Optik 264 -0,3% 23,9% 71,2% 800 n.a. n.a. -1,0 




Exhibit 5 – List of analyzed transactions of Optical Retailers 







Coastal Contacts. CA Essilo International FR Apr/14 389,8 1,98 n.a. 
National Vision US KKR US Mar/14 1000,0 1,27 n.a. 
Synsam Nordic DN CVC Capital Partners UK Mar/14 625,2 1,62 8,53 
Erroca IR Luxottica IT Jan/14 27,2 1,09 n.a. 
Vogue Optical  CA New Look Eyewear  CA Dec/13 69,5 1,89 n.a. 
Megane Top JP Tomizawa JP Aug/13 470,6 0,93 6,75 
Multiopticas Int. ES Luxottica IT May/13 122,9 2,02 25,64 
High Tech 
Sunglasses MX Luxottica IT Feb/13 22,7 1,13 n.a. 
Alain Mikli FR Luxottica IT Jan/13 119,9 1,55 n.a. 
















Mean 3,0% 69,7% 18,8% 2,3x 12,4x -0,3 
Median 3,9% 75,6% 17,3% 2,3x 12,4x -0,3 
Source: Gurufocus; Company reports 
Source: Zephyr – Bureau Van Dijk 
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Exhibit 7 – List of Portuguese Optical Retailers (Turnover > Eur 1.0 Mn) 









Grandvision Portugal 67,4 0,3% 17,2% 3,4 177 
Mais Óptica  11,4 3,5% 3,1% -1,1 23 
Alberto Oculista 9,8 1,4% 17,0% 2,2 29 
Grupo OMB 7,4 -1,3% 8,6% 6,4 34 
Optivisão 7,3 -4,5% 6,6% -0,4 270 
Sunglass Hut Portugal 6,7 8,9% -2,9% 2,2 22 
Ergovisão 4,0 0,1% -0,8% -54,7 29 
Oculista Central das Avenidas 4,0 -6,9% 3,9% 0,4 2 
Novo Oculista de Loures 3,4 0,1% 8,6% 3,3 3 
Multivista 2,5 6,5% 10,9% 0,6 n.a. 
Adão Oculista 2,4 -8,1% 6,3% -1,2 12 
Óptica Lince 2,3 -0,7% 12,6% 1,9 13 
Visionlab 2,1 -1,6% 8,7% 42,3 1 
Grupótico 2,1 0,4% 19,3% 0,6 32 
Vítor Almeida - Oculistas 2,1 -5,5% 4,7% 0,0 5 
Carlos & Leonor - Óptica 2,0 2,1% 4,2% 7,2 12 
Brancóptica 1,9 -2,0% 38,3% -0,1 n.a. 
Antunes Oculistas 1,7 -12,5% 2,3% -0,9 9 
Oculista de Santa Maria 1,7 0,3% 10,6% 2,8 n.a. 
Vitriu 1,7 7,7% 23,7% 1,0 n.a. 
Óptica Médica Rogério 1,6 -5,5% 9,7% 5,4 12 
Centro Óptico Boa Imagem 1,5 6,8% 11,4% 0,6 8 
Optisun - Ópticas 1,5 -6,4% 6,5% 5,0 n.a. 
Cruz Oculista 1,5 -2,7% 11,4% 1,6 5 
Oculista Central Torreense 1,4 -1,2% 13,3% -1,3 n.a. 
Gallery de Visão 1,4 5,2% 11,8% -2,6 n.a. 
Centro Óptico Ibérico 1,4 -0,1% 27,6% -0,7 5 
Jaime Oculista 1,4 -1,7% 14,0% -0,1 7 
Ópticas Parente II 1,2 -0,4% 15,7% 0,6 6 
Alípios 1,0 n.a. 15,9% -0,2 5 
Source: Amadeus; Eur’ 000 
 
384,3 378,3 375,5 
395,9 
2010 2011 2012 2013 
Market Size of Eyecare Products in Portugal 
(Eur Mn) 
Source: Amadeus  
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Exhibit 8 – Distribution Channels of Hearing Aid Equipment  
 
 
Exhibit 9 – List of largest Hearing Aid Equipment Companies  













Sonova 1600 15,2% 69,0% 22,5% 5,08 20,37 -0,8 
William Demant 1241 10,8% 72,5% 21,2% 2,86 14,74 -0,2 
Siemens Hearing Division 918 n.a. n.a. 19% 2,2 12,0 n.a. 
GN Store Nord 899 15,2% 60,0% 22,4% 3,3 14,32 1,0 
Amplifon SpA 830 5,3% 76,5% 14,1% 1,37 9,39 2,4 
Rion 129 2,2% 53,0% 14,0% 0,92 5,64 -0,7 
 













Mean 9,8% 18,8% 66.2% 2.4x 12.2x 0,3x 
Median 10,8% 19,9% 69.0% 2.5x 12.5x -0.2x 
 
Exhibit 10 – List of transactions of Hearing Aid Equipment companies 
Target Country Acquiror Country Completed date 
Deal Value 
(USD Mn) 




B2C SAS FR 5M Ventures IT Jul/14 30,0 n.a. n.a. 
Medtechnica Ortophone IR Amplifon SpA FR Jun/14 27,3 n.a. n.a. 
Williams Medical  UK DCC Healthcare IR Jun/14 75,4 0,78 8,94 
Audika Italia Srl IT Amplifon SpA IT Apr/14 9,8 0,76 9,46 
Rion Co. JP Resona Bank JP Jan/14 9,5 1,11 8,16 
Amplifon SpA IT Fidelity International BM Nov/13 22,7 1,00 5,82 
Zavod Slukhovykh RU KEM OOO RU May/13 22,3 6,36 n.a. 
NHC Group Pty AU Amplifon SpA IT Sep/12 481,3 4,41 19,52 
Maxtone TU Amplifon SpA IT Jan/12 1,3 n.a. n.a. 
Amplifon SpA IT Ms. Anna Formiggini IT Oct/10 674,7 1,19 8,75 
 
 









Distribution Channel Mix 
(U.S, 2012) 
Source: William Demant Report, 2013 
Source:	  Zephyr	  
Source: Gurufocus; Company reports 
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Set/14 Jul/15 Mai/16 Mar/17 Dez/17 Out/18 Ago/19 Jun/20 
Exit of investment 
Increase # cross-selling stores to 33 
Increase # cross-selling stores to 31 
Increase # cross-selling stores to 16 
Savings in SG&A, Personnel and Materials 
Acquisition of Remaining Optical Chains 
Start Selling Hearing Equip. In 9 Stores 
Acquisition of Sonotone and 2 Optical Chains 
Recruitment of Management Team 
Legal and Financial DD 
Implementation Roadmap 
Exhibit 11 - List of 8 largest Hearing Aid companies in Portugal 













Hidden Hearing 19.6 0.3% 16.7 -0.2x 82.7% 20.3% 16.5% 
Minisom 15.1 -5.7% 17.3 0.3x 81.8% 5.0% 24.9% 
Widex 10.2 7.5% 4.8 1.7x 68.6% 6.0% -4.9% 
GAES 4.5 -1.3% 1.3 3.9x 77.1% -1.3% -10.8% 
Amplifon Portugal 4.2 5.4% 1.9 1.0x 82.3% 15.6% -1.7% 
Casa Sonotone + 
Audiosom 2.1 -10.3% 0.7 -0.4x 73.7% 8.4% 6.6% 
Novacústica 0.6 305.5% 0.2 -8.1x 65.5% 2.0% -41.4% 
Audiovital 0.6 -6.9% 0.2 -1.0x 79.7% 8.9% 9.2% 
 
 
Exhibit 12 – Number of stores by District 
  Braga Porto Aveiro Viseu Guarda Coimbra Leiria C.Branco Lisboa Santarém Setúbal Total 
Adão Oculista  11 1         12 
Ópticas Lince  2  1 6  1 1  2  13 
Carlos & Leonor         11 1  12 
Antunes Oculista         1  8 9 
Jaime Oculista 5 1  1        7 
Parente II    5  1      6 
Alípio Oculista       1   4  5 
Total 5 14 1 7 6 1 2 1 12 7 8 64 
 
Exhibit 13 – Number of stores with hearing aids, by year 
 Braga Porto Aveiro Viseu Guarda Coimbra Leiria C. Branco Lisboa Santarém Setúbal Total 2015 1 2  1 1    2 1 1 9 2016 2 3  2 2    3 2 2 16 2017 2 5 1 3 3 1 1 1 5 2 3 27 
2018 3 6 1 3 3 1 1 1 6 3 3 31 
2019 3 7 1 3 3 1 1 1 7 3 3 33 
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Exhibit 15 – Compensation Package of Management Team and Audiologists 
 Monthly figures, € CEO CFO/COO Audiologists 
Base Salary  5 000 4 000 1 000 
Lunch Allowance  150 150 150 
Social Security  24 325 19 460 4 865 
Fringe Benefits  10 400 8 400 - 
Total Annual Expense 106 378 85 513 20 518 
 
Exhibit 16 – Fringe Benefits for Management Team 
Monthly figures, € CEO CFO/COO 
Car  500 400 
Fuel 150 100 
Cell phone  150 150 
Medical insurance 800 600 
Total 10 400 8 400 
 
Exhibit 17 – Adverse Scenarios’ Income Statement 2019   
 
Eur '000 Scenario 2 
Revenues 11 997 
COGS 3 971 
Gross Margin 8 026 
% of Revenues 66,9% 
Personnel 3 940 
SG&A 2 542 
Other Gains/Expenses -315 
EBITDA 1 859 
% of Revenues 15,0% 
Dep & Amortizations 600 
EBIT 1 259 
Financial Expenses 43 
EBT 1 215 
Taxes 334 
Net Income 881 
% of Revenues 7.3% 
 
Exhibit 18 – Sensitivity on amount of Debt 
Net Debt/EBITDA New Debt (Eur ‘000) Multiple on Investment 
1,0x 784 2,31x 
1,5x 1 424 2,45x 
2,0x 2 064 2,61x 
2,5x 2 704 2,80x 
3,0x 3 344 3,01x 
 
Eur '000 Scenario 3 
Revenues 16 054 
COGS 5 481 
Gross Margin 10 573 
% of Revenues 66,9% 
Personnel 5 207 
SG&A 3 250 
Other Gains/Expenses -290 
EBITDA 2 407 
% of Revenues 15,0% 
Dep & Amortizations 6013 
EBIT 1 794 
Financial Expenses 63 
EBT 1 731 
Taxes 483 
Net Income 1 255 
% of Revenues 7.9% 
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Exhibit 19 – Equity Discount Rate  
Risk-free Rate 2,75% 
Market Risk Premium (PT Equities) 7,39% 
Market Beta (Healthcare Products) 0,89 
Equity Discount Rate 9,33% 
 
Exhibit 20 – Euribor 3 Months Estimates 
Year Q1 Q2 Q3 Q4 12 Months 
2015 0,63% 0,67% 0,64% 0,58% 1,263% 
2016 0,58% 0,47% 0,43% 0,47% 0,976% 
2017 0,47% 0,42% 0,37% 0,32% 0,792% 
2018 0,28% 0,28% 0,29% 0,26% 0,548% 
2019 0,29% 0,29% 0,29% 0,29% 0,583% 
 
Exhibit 21 – Weighted Average Cost of Capital, 2014-2019 
 2014 2015 2016 2017 2018 2019 Debt Disc. Rate 4,66% 5,26% 4,98% 4,79% 4,55% 4,58% 
Equity Disc. Rate 9,33% 9,33% 9,33% 9,33% 9,33% 9,33% 
Tax Rate 30,5% 29,5% 27,5% 27,5% 27,5% 27,5% 
Debt (Eur ‘000) 5 164 3 436 2 577 1 718 859 0 
Equity (Eur ‘000) 9 923 10 690 11 551 12 519 13 790 15 406 
WACC 7,24% 7,96% 8,28% 8,62% 8,97% 9,33% 
 
Exhibit 22 – Discounted Cash Flows 
Eur '000 2015 2016 2017 2018 2019 
NOPAT 926 985 1 058 1 328 1 644 
 + Depreciations 613 613 613 613 613 
- Capex 613 613 613 613 613 
Non-Cash Working Capital 3 212 3 256 3 351 3 480 3 617 
- Change in NCWC 100 45 94 130 137 
+ Terminal Value - - - - 25 667 
FCFF 826 940 964 1 198 27 174 
Discounted FCFF 766 845 755 852 17 399 
Enterprise Value 20 576         
Net Debt -2 591         
Equity Value 22 587         
 
Exhibit 23 – Reduction in Personnel Expenses 
 Eur Management HR Marketing 
Monthly Salary  2 800 1 200 1 200 
Lunch Allowance 150 150 150 
Annual Social Security 13 622 5 838 5 838 
Total Anual Savings 381 324 145 745 145 745 
	  
Source: The Economy Forecast Agency 
